Pharmacokinetics and Pharmacodynamics Specialists analyze the processes that govern the movement of drugs within the body and their interactions with biological systems. Pharmacokinetics (PK) focuses on how the body absorbs, distributes, metabolizes, and eliminates drugs. It helps determine the right dosage and timing for medications to achieve therapeutic effects without causing harm. On the other hand, pharmacodynamics (PD) examines the relationship between drug concentration at the site of action and the resulting effects on the body, including efficacy and potential side effects. These specialists play a crucial role in optimizing drug therapy by ensuring that drugs are used safely and effectively across different populations. Their expertise also aids in the development of new drug delivery systems that improve drug bioavailability and therapeutic outcomes.
Pharmacologists, clinicians, and drug developers throughout the drug development process. They conduct studies to understand the drug's behavior in the body, ensuring it reaches the target site in the appropriate amount and at the right time. Pharmacokinetics and pharmacodynamics specialists are also involved in predicting drug-drug interactions and personalizing treatments based on individual genetic, metabolic, and physiological factors. Their research ensures the safe and effective use of drugs in clinical settings, contributing to the ongoing development of new therapies for a wide range of conditions.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada